Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schedule Kratom? Promoted By Former US FDA Commissioner, Opposed By Former Top HHS Official

May 25 2021

• By Malcolm Spicer

Related Content

DEA Takes Comments On Kratom, But Keeps Eye On Scheduling

Oct 14 2016

With Seizure in Florida, FDA Targets Kratom As Unsafe For Any Use

May 25 2021

US HHS Pulled Recommendation To Make Kratom A Controlled Substance, But Kept Mum On Change

Jan 29 2021

Additional Topics

International United States US States Dietary Supplements FDA Leadership Advertising, Marketing & Sales Commercial Compliance Ingredients Enforcement Politics Policy Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window